Pacific Biosciences of California Inc (PACB)’s Market Momentum: Closing Strong at 1.22, Up 1.67

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

As of close of business last night, Pacific Biosciences of California Inc’s stock clocked out at $1.22, up 1.67% from its previous closing price of $1.20. In other words, the price has increased by $1.67 from its previous closing price. On the day, 8.61 million shares were traded. PACB stock price reached its highest trading level at $1.26 during the session, while it also had its lowest trading level at $1.2.

Ratios:

To gain a deeper understanding of PACB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.13 and its Current Ratio is at 12.63. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.32.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when HENRY CHRISTIAN O sold 12,497 shares for $1.41 per share. The transaction valued at 17,583 led to the insider holds 2,225,357 shares of the business.

Van Oene Mark sold 6,486 shares of PACB for $9,126 on Mar 03 ’25. The insider now owns 1,497,695 shares after completing the transaction at $1.41 per share. On Mar 03 ’25, another insider, Farmer Michele, who serves as the insider of the company, sold 2,973 shares for $1.41 each. As a result, the insider received 4,183 and left with 184,619 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 359064320 and an Enterprise Value of 627761792. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.17 while its Price-to-Book (P/B) ratio in mrq is 0.74. Its current Enterprise Value per Revenue stands at 4.076 whereas that against EBITDA is -2.524.

Stock Price History:

The Beta on a monthly basis for PACB is 2.01, which has changed by -0.66757494 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, PACB has reached a high of $4.23, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -23.86%, while the 200-Day Moving Average is calculated to be -29.91%.

Shares Statistics:

It appears that PACB traded 11.29M shares on average per day over the past three months and 10141730 shares per day over the past ten days. A total of 273.86M shares are outstanding, with a floating share count of 243.53M. Insiders hold about 11.08% of the company’s shares, while institutions hold 84.43% stake in the company. Shares short for PACB as of 1740700800 were 61979163 with a Short Ratio of 5.49, compared to 1738281600 on 60400275. Therefore, it implies a Short% of Shares Outstanding of 61979163 and a Short% of Float of 23.990000000000002.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular